Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02JDL
|
||||
| Drug Name |
Porfimer Sodium
|
||||
| Synonyms |
Photofrin; Photofrin
|
||||
| Indication | Non-small cell lung cancer [ICD10:C33-C34] | Approved | [551871] | ||
| Company |
Concordia Laboratories Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Low-density lipoprotein receptor | Target Info | Modulator | [556264] | |
| NetPath Pathway | FSH Signaling Pathway | ||||
| IL2 Signaling Pathway | |||||
| WikiPathways | DNA Damage Response (only ATM dependent) | ||||
| Statin Pathway | |||||
| Wnt Signaling Pathway | |||||
| Wnt Signaling Pathway and Pluripotency | |||||
| Visual phototransduction | |||||
| Lipid digestion, mobilization, and transport | |||||
| Oncostatin M Signaling Pathway | |||||
| SREBF and miR33 in cholesterol and lipid homeostasis | |||||
| SREBP signalling | |||||
| Folate Metabolism | |||||
| Vitamin B12 Metabolism | |||||
| Selenium Micronutrient Network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.